InsidersTradesSigma
Browse the complete record of transactions filed by Vignola Mark J., Chief Financial Officer. Director active across 1 companies, notably Terns Pharmaceuticals, Inc.. Cumulatively, 1 reports have been logged. Total volume traded: €10k. The latest transaction was disclosed on 31 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Mark J. Vignola is the Chief Financial Officer at Terns Pharmaceuticals, Inc. He is responsible for the company's financial management, including financial planning and risk management. Mark plays a crucial role in developing financial strategies to support the company's growth and sustainability.